Filing Flows

Filing Flows › Vir Biotechnology (VIR) › Who owns the stock

Who owns Vir Biotechnology (VIR) stock

230 funds reported Vir Biotechnology (VIR) shares in their latest 13F filings, worth $1.5B in all. The largest holder is BlackRock ($211M). Last quarter 108 funds added to their stakes and 107 cut them.

Largest holders of VIR (13F)Largest holders of VIR (13F)BlackRock$211MArch Venture Management, LLC$129MVanguard Portfolio Management LLC$117MSB Investment Advisers (uk)$112MState Street$102MGSK$87.1MVanguard Group$75.7MVanguard Capital Management LLC$65.1MPoint72 Asset Management, L.P.$57.7MGeode Capital Management, LLC$34.1M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock20,678,283$211Mincrease2026-06-30
Arch Venture Management, LLC12,694,163$129Mdecrease2026-06-30
Vanguard Portfolio Management LLC11,495,215$117Mincrease2026-06-30
SB Investment Advisers (uk)10,948,093$112Munchanged2026-06-30
State Street9,964,151$102Mincrease2026-06-30
GSK8,550,954$87.1Munchanged2026-06-30
Vanguard Group12,548,944$75.7Mdecrease2025-12-31
Vanguard Capital Management LLC6,388,775$65.1Mincrease2026-06-30
Point72 Asset Management, L.P.5,666,821$57.7Mincrease2026-06-30
Geode Capital Management, LLC3,348,366$34.1Mincrease2026-06-30
Dimensional Fund Advisors LP3,119,421$31.8Mincrease2026-06-30
ADAR1 Capital Management, LLC2,456,677$25.0Mdecrease2026-06-30
Goldman Sachs Group2,365,219$24.1Mdecrease2026-06-30
FMR LLC2,318,294$23.6Mincrease2026-06-30
Morgan Stanley2,211,077$22.5Mdecrease2026-06-30

Vir Biotechnology's latest quarter

Vir Biotechnology, Q2 2026: revenue $239M (197× year over year), operating margin 30.7%, net earnings $80.1M, operating cash flow $123M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most VIR stock?

By the latest 13F filings: BlackRock ($211M); Arch Venture Management, LLC ($129M); Vanguard Portfolio Management LLC ($117M); SB Investment Advisers (uk) ($112M); State Street ($102M).

What is the short interest in VIR?

16,236,717 shares were sold short at the 2026-10-15 settlement, 8.39% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.